PAVmed (PAVM)
4.85
-0.13 (2.61%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G PAVmed Inc. Filed by: Two Seas Capital LP
May 15, 2026 5:51 PM - SEC Filing
Form 8-K PAVmed Inc. For: May 15
May 15, 2026 8:06 AM - SEC Filing
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026 8:00 AM - PR NewsWire
Form 10-Q PAVmed Inc. For: Mar 31
May 14, 2026 5:18 PM - SEC Filing
Form SCHEDULE 13G PAVmed Inc. Filed by: FIRST MANHATTAN CO. LLC.
May 14, 2026 4:35 PM - SEC Filing
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
May 14, 2026 8:00 AM - PR NewsWire
Form SCHEDULE 13G/A PAVmed Inc. Filed by: Ayrton Capital LLC
May 11, 2026 5:58 PM - SEC Filing
Form DEF 14A PAVmed Inc. For: Apr 30
May 1, 2026 9:29 AM - SEC Filing
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026
May 1, 2026 8:31 AM - PR NewsWire
Form DEFA14A PAVmed Inc.
April 30, 2026 5:04 PM - SEC Filing
Form ARS PAVmed Inc. For: Dec 31
April 30, 2026 5:03 PM - SEC Filing
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
April 30, 2026 8:31 AM - PR NewsWire
Form EFFECT PAVmed Inc.
April 30, 2026 6:16 AM - SEC Filing
Form 424B3 PAVmed Inc.
April 29, 2026 4:18 PM - SEC Filing
Lucid Diagnostics completes $18 million stock offering
April 24, 2026 10:24 AM - StreetInsider
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
April 24, 2026 10:24 AM - PR NewsWire
Lucid Diagnostics prices $18 million stock offering at $1 per share
April 23, 2026 8:30 AM - StreetInsider
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
April 23, 2026 8:30 AM - PR NewsWire
PAVmed (PAVM) files for 9.23M share offering by selling stockholders
April 21, 2026 6:11 AM - StreetInsider
Form S-3 PAVmed Inc.
April 21, 2026 6:04 AM - SEC Filing
Form SCHEDULE 13G/A PAVmed Inc. Filed by: Tasso Partners, LLC
April 14, 2026 4:06 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: Lee Victoria Tou-ho
April 13, 2026 4:11 PM - SEC Filing
Form 3 PAVmed Inc. For: Mar 24 Filed by: Lee Victoria Tou-ho
April 13, 2026 4:08 PM - SEC Filing
Form SCHEDULE 13G PAVmed Inc. Filed by: Scopia Holdings LLC
April 13, 2026 11:13 AM - SEC Filing
Form SCHEDULE 13D PAVmed Inc. Filed by: Aklog Lishan
April 9, 2026 8:57 PM - SEC Filing
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
April 9, 2026 8:01 AM - PR NewsWire
Form SCHEDULE 13G PAVmed Inc. Filed by: NAGELBERG DAVID S
April 8, 2026 8:41 PM - SEC Filing
Form SCHEDULE 13G PAVmed Inc. Filed by: Dols Scott V.
April 8, 2026 6:09 PM - SEC Filing
Form 3 PAVmed Inc. For: Mar 27 Filed by: Tasso Partners, LLC
April 6, 2026 9:47 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: Aklog Lishan
April 3, 2026 6:54 PM - SEC Filing
Form SCHEDULE 13G PAVmed Inc. Filed by: Kallman Craig
April 3, 2026 6:28 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: MCGRATH DENNIS M
April 3, 2026 4:52 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: Glennon Michael J
April 3, 2026 4:51 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: Baxter Timothy E
April 3, 2026 4:49 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: White Debra
April 3, 2026 4:48 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: Sparks Ronald M
April 3, 2026 4:47 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: Agrawal Sundeep
April 3, 2026 4:47 PM - SEC Filing
Form SCHEDULE 13G/A PAVmed Inc. Filed by: Tasso Partners, LLC
April 3, 2026 4:47 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: Gordon Michael Adam
April 3, 2026 4:47 PM - SEC Filing
Form 4 PAVmed Inc. For: Apr 02 Filed by: O'Neil Shaun
April 3, 2026 4:44 PM - SEC Filing
PAVmed names Joseph Virgilio to lead medical device unit
April 2, 2026 8:01 AM - StreetInsider
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
April 2, 2026 8:01 AM - PR NewsWire
Form S-8 PAVmed Inc.
April 2, 2026 6:03 AM - SEC Filing
Form S-8 PAVmed Inc.
April 2, 2026 6:03 AM - SEC Filing
Form 8-K PAVmed Inc. For: Mar 30
March 30, 2026 8:10 AM - SEC Filing
PAVmed reports Q4 2025 results, strengthens capital structure
March 30, 2026 8:02 AM - StreetInsider
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 30, 2026 8:01 AM - PR NewsWire
Form 8-K PAVmed Inc. For: Mar 27
March 27, 2026 5:16 PM - SEC Filing
Form 10-K PAVmed Inc. For: Dec 31
March 27, 2026 5:08 PM - SEC Filing
Lucid Diagnostics reports Q4 revenue of $1.5 million, secures VA contract
March 26, 2026 8:02 AM - StreetInsider
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 26, 2026 8:01 AM - PR NewsWire
PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026
March 16, 2026 9:01 AM - PR NewsWire
Full Article List